Search filters

Filters

Clear All

Phase

  • 2
  • 2
  • 1
  • 1
  • 4
  • 17
  • 34
  • 9
  • 1
  • 4
  • 1
  • 28

Found 34 type 2 diabetes mellitus trials

A listing of type 2 diabetes mellitus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients

All genders
Interventional
Compared to the general population, diabetic patients have a significantly higher rate of inadequate bowel preparation. The European Society of Gastrointestinal Endoscopy (ESGE) guideline recommends polyethylene glycol (PEG) as the preferred bowel-cleansing agent, but there is currently no standardized bowel preparation protocol specifically for diabetic patients. Previous studies have shown …

Trial for Type 2 Diabetes

18 years - 100 years
All genders
A study to evaluate the effectiveness of XYZ drug for Type 2 Diabetes treatment.
 STRIDE Study : The Effects of semaglutide on functional capacity in pith type 2 diabetes and peripheral arterial disease

STRIDE Study : The Effects of semaglutide on functional capacity in pith type 2 diabetes and peripheral arterial disease

18 years - 99 years
All genders
Phase 3
This is a 52 week, randomized, double-blind, placebo-controlled trial comparing semaglutide 1 mg versus placebo both added to standard of care and administered once weekly in subjects with Type 2 Diabetes Mellitus with Intermittent Claudication.
 Investigation of the Effect of Branched Chain Amino Acids on Fat-Induced Insulin Resistance in Healthy Adults.

Investigation of the Effect of Branched Chain Amino Acids on Fat-Induced Insulin Resistance in Healthy Adults.

18 years - 39 years
All genders
Phase 1
Elevations in plasma levels of branched chain amino acids (BCAAs, comprising leucine, valine, and isoleucine), a large component of protein, are strongly associated with insulin resistance and type 2 diabetes, but mechanisms for this relationship are unclear. This protocol will determine whether excess BCAAs worsen free fatty acid-induced insulin resistance. …
 CureGN-Diabetes: Ancillary Study to CureGN

CureGN-Diabetes: Ancillary Study to CureGN

18 years - 99 years
All genders
Interventional
There are several different types of glomerular diseases, such as minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and immunoglobulin A nephropathy (IgAN). Over time, these diseases may cause kidney damage. Because these kidney diseases are rare, it is difficult for individual researchers to gather a large …

Evaluating Study Drug STx-02 in Subjects Who Have Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia

18 years - 65 years
All genders
Phase 3
Interventional
The Study Product we are testing in this research study is called STx-02. This study is being done to learn more about how safe, tolerable and effective the Study Product is in participants with T1D with impaired awareness of low blood sugar and who have severe hypoglycemia. Participation could last …

A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia (SUGR)

18 years - 65 years
All genders
Phase 1/2
Interventional
This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe recurrent hypoglycemia. The study will also help establish the optimal treatment dose. Although this study is open to patients with all HLA or blood types, immunosuppression to …
11 - 20 of 34